YI

111 Inc ADR

2.85

Oct 30 • 4:00 PM ET -0.13 (-4.36%)

Healthcare Medical Distribution China Nano NASD

Peers: POM RDGT HKPD MEDS COR MCK AHG UPC CPHI SY

Index	-
Market Cap	14.79M
Enterprise Value	138.09M
Income	-15.20M
Sales	1.50B
Book/sh	-13.02
Cash/sh	10.82
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	1063
IPO	Sep 12, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	0.01
P/B	-
P/C	0.26
P/FCF	-
EV/EBITDA	-
EV/Sales	0.09
Quick Ratio	0.51
Current Ratio	1.07
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-1.73
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	47.72% 33.28%
Sales past 3/5Y	-4.53% 8.01%
EPS Y/Y TTM	-45.45%
Sales Y/Y TTM	-23.90%
EPS Q/Q	-109.25%
Sales Q/Q	-23.76%
Earnings	Sep 17 BMO
EPS/Sales Surpr.	- -

Insider Own	1.82%
Insider Trans	-94.39%
Inst Own	2.22%
Inst Trans	73.60%
ROA	-4.99%
ROE	-
ROIC	-
Gross Margin	5.73%
Oper. Margin	-0.52%
Profit Margin	-1.02%
SMA20	-7.11%
SMA50	-14.02%
SMA200	-43.84%
Trades

Shs Outstand	5.19M
Shs Float	5.09M
Short Float	0.08%
Short Ratio	0.31
Short Interest	0.00M
52W High	11.17 -74.49%
52W Low	2.48 14.92%
Volatility	6.41% 4.72%
ATR (14)	0.19
RSI (14)	32.73
Beta	0.76
Rel Volume	1.56
Avg Volume	13.90K
Volume	21,640

Perf Week	-0.35%
Perf Month	-13.77%
Perf Quarter	-21.21%
Perf Half Y	-52.50%
Perf YTD	11.33%
Perf Year	-35.08%
Perf 3Y	-87.33%
Perf 5Y	-94.52%
Perf 10Y	-
Recom	1.00
Target Price	12.01
Prev Close	2.98
Price	2.85
Change %	-4.36%

Consensus

Strong Buy

Avg. Price Target

$12.01

Implied Upside

+321.4%

Analysts1incl. previous ratings

Rating Distribution1 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Apr 15, 2021	Resumed	CCitigroup	Buy	$16	+461.4%

Oct-26-26 04:00AM	111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee (PR Newswire)
Sep-28-26 04:30AM	111, Inc. Announces Establishment of the Special Committee (PR Newswire)
Sep-17-26 04:25AM	111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company (PR Newswire)
03:00AM	111, Inc. Announces Second Quarter 2026 Unaudited Financial Results (PR Newswire)
Jun-04-26 04:00AM	111, Inc. Announces First Quarter 2026 Unaudited Financial Results (PR Newswire) -10.27%
03:00AM	Loading…
Apr-09-26 03:00AM	111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results (PR Newswire)
Dec-17-25 01:00AM	111, Inc. Announces Third Quarter 2025 Unaudited Financial Results (PR Newswire)
Sep-17-25 02:00AM	111, Inc. Announces Second Quarter 2025 Unaudited Financial Results (PR Newswire) -6.24%
Jun-19-25 03:03AM	111, Inc. Announces First Quarter 2025 Unaudited Financial Results (PR Newswire)
Apr-21-25 04:29PM	111 Inc (YI) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic Efficiency (GuruFocus.com) +9.40%
Mar-20-25 03:03PM	111, Inc. (YI) Q4 2024 Earnings Call Transcript (SeekingAlpha) -7.82%
01:00AM	111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results (PR Newswire)
Mar-12-25 07:00AM	111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025 (PR Newswire)
Feb-20-25 05:00AM	111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow (PR Newswire)
Feb-11-25 08:00AM	111, Inc. Regains Compliance with NASDAQ Requirement (PR Newswire)
05:00AM	Loading…
Jan-08-25 05:00AM	111, Inc. Announces ADS Ratio Change (PR Newswire) -5.26%
Nov-28-24 06:33AM	111, Inc. Achieves Sustained Profitability in Q3 2024 (TipRanks)
02:01AM	111 Inc (YI) Q3 2024 Earnings Call Highlights: Operational Profitability Amidst Flat Revenue Growth (GuruFocus.com)
Nov-27-24 05:02AM	111: Q3 Earnings Snapshot (Associated Press Finance) +49.54%
01:00AM	111, Inc. Announces Third Quarter 2024 Unaudited Financial Results (PR Newswire)
Nov-21-24 05:00AM	111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024 (PR Newswire)
Nov-04-24 06:00AM	111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow (PR Newswire)
05:00AM	111, Inc. Announces Change to Board of Directors (PR Newswire)
Oct-22-24 05:10AM	111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024 (PR Newswire) +6.26%
Oct-18-24 05:00AM	111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow (PR Newswire) +6.02%
Oct-10-24 06:02AM	111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China (PR Newswire) -6.34%
Sep-27-24 05:00PM	111, Inc. Announces Receipt of Notification from Nasdaq (PR Newswire) +11.18%
Sep-13-24 07:30AM	111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation (PR Newswire)
Aug-29-24 02:00AM	111, Inc. Announces Second Quarter 2024 Unaudited Financial Results (PR Newswire) -9.30%
Aug-27-24 08:00AM	111, Inc. to Participate in Fireside Chat with Water Tower Research on September 5, 2024 (PR Newswire)
01:00AM	Loading…
Jul-29-24 01:00AM	111 to Announce Second Quarter 2024 Unaudited Financial Results on August 29, 2024 - Conference Call to Follow (PR Newswire)
Jul-19-24 08:45AM	111 Announces Appointment of New Auditor (PR Newswire)
Jul-17-24 01:31AM	111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024 (PR Newswire) -5.31%
Jun-11-24 03:57AM	111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility (PR Newswire)
May-23-24 08:52AM	YI Stock Earnings: 111 Reported Results for Q1 2024 (InvestorPlace) -5.31%
04:43AM	111, Inc. Announces First Quarter 2024 Unaudited Financial Results (PR Newswire)
Apr-30-24 02:30AM	111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow (PR Newswire)
Mar-22-24 11:36AM	111, Inc. (NASDAQ:YI) Q4 2023 Earnings Call Transcript (Insider Monkey) -13.11%
Mar-21-24 04:47AM	111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results (PR Newswire) -20.26%
Mar-01-24 04:00AM	111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow (PR Newswire)
Feb-27-24 08:58AM	111 Announces Receipt of Withdrawal of Going Private Proposal (PR Newswire)
Dec-01-23 09:20AM	111, Inc. (NASDAQ:YI) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.03%
Nov-30-23 01:00AM	111, Inc. Announces Third Quarter 2023 Unaudited Financial Results (PR Newswire) -7.44%
Nov-13-23 12:10AM	111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow (PR Newswire)
Aug-31-23 08:09AM	111, Inc. (NASDAQ:YI) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-24-23 02:00AM	111, Inc. Announces Second Quarter 2023 Unaudited Financial Results (PR Newswire) -5.32%
Jul-31-23 05:59AM	111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow (PR Newswire)
Jun-15-23 05:03AM	111: Q1 Earnings Snapshot (AP Finance)
01:15AM	111, Inc. Announces First Quarter 2023 Unaudited Financial Results (PR Newswire)
May-25-23 02:05AM	111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow (PR Newswire)
Mar-27-23 06:26AM	111, Inc. (NASDAQ:YI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-23-23 05:07AM	111: Q4 Earnings Snapshot (AP Finance)
02:17AM	111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results (PR Newswire)
Mar-02-23 02:35AM	111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow (PR Newswire)
Feb-16-23 12:33AM	111, Inc. Hosts Hua Medicine Launches First Official Flagship Store (PR Newswire)
Dec-01-22 02:33AM	111, Inc. Announces Third Quarter 2022 Unaudited Financial Results (PR Newswire)
Nov-08-22 01:09AM	111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow (PR Newswire)
Sep-23-22 12:30AM	111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee (PR Newswire)
Sep-09-22 05:53AM	111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company (PR Newswire) +7.54%
Aug-25-22 02:18AM	111, Inc. Announces Second Quarter 2022 Unaudited Financial Results (PR Newswire) +12.92%
Aug-08-22 01:19PM	What You Need To Know About 111, Inc.'s (NASDAQ:YI) Investor Composition (Simply Wall St.)
Aug-05-22 02:26AM	111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow (PR Newswire) -9.70%
Jun-16-22 03:58AM	111, Inc. Announces First Quarter 2022 Unaudited Financial Results (PR Newswire) -11.32%
May-26-22 04:59AM	111 to Announce First Quarter 2022 Unaudited Financial Results on June 16, 2022 - Conference Call to Follow (PR Newswire) +11.97%
May-05-22 01:46PM	111 (NASDAQ:YI) adds CN¥17m to market cap in the past 7 days, though investors from a year ago are still down 82% (Simply Wall St.)
05:18AM	111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act (PR Newswire)
Apr-13-22 05:02AM	111, Inc. Provides Urgently-needed Items and Online Services to Support Shanghai's Fight Against Covid-19 Pandemic (PR Newswire)
Mar-17-22 03:20AM	111, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results (PR Newswire) +7.73%
Mar-14-22 07:35AM	111, Inc. Becomes First Online Retail Platform for BGI's SARS-CoV-2 Virus Antigen Detection Kits (PR Newswire) -15.50%
Mar-04-22 04:24AM	111, Inc. Reaches Strategic Partnership on Direct Supply with Beilin Pharmaceutical to Blaze New Trails in Digital Development of Chinese Patent Medicine (PR Newswire) -7.13%
Mar-01-22 08:55AM	Is 111, Inc.'s (NASDAQ:YI) Shareholder Ownership Skewed Towards Insiders? (Simply Wall St.)
Feb-22-22 03:38AM	111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow (PR Newswire)
Jan-03-22 09:38PM	Wellspring Financial Advisors, LLC Buys iShares Core S&P Mid-Cap ETF, Vanguard Mid-Cap ... (GuruFocus.com)
Nov-22-21 12:14PM	Further weakness as 111 (NASDAQ:YI) drops 11% this week, taking three-year losses to 51% (Simply Wall St.) -13.61%
Nov-19-21 12:31AM	111, Inc. Announces Third Quarter 2021 Unaudited Financial Results (PR Newswire)
Nov-01-21 04:57PM	/C O R R E C T I O N -- 111, Inc./ (PR Newswire)
Oct-28-21 07:00PM	111 to Announce Third Quarter 2021 Unaudited Financial Results on November 19, 2021 - Conference Call to Follow (PR Newswire)
Oct-25-21 07:00AM	111, Inc. Announces Strategic Partnership with Chugai Pharma China Co., Ltd. to Accelerate Innovations in Chronic Disease Management (PR Newswire)
Sep-17-21 07:00AM	111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference (PR Newswire)
Sep-07-21 05:00AM	111, Inc. Announces $10 Million Share Repurchase Program (PR Newswire) +17.38%
Aug-27-21 02:30AM	111, Inc. Announces Second Quarter 2021 Unaudited Financial Results (PR Newswire)
Aug-16-21 08:00AM	111, Inc. Deepens Partnership with Bayer Healthcare (PR Newswire) -6.14%
Aug-13-21 07:16AM	What Type Of Shareholders Make Up 111, Inc.'s (NASDAQ:YI) Share Registry? (Simply Wall St.)
Aug-09-21 07:30AM	111 to Announce Second Quarter 2021 Unaudited Financial Results on August 27, 2021 -Conference Call to Follow (PR Newswire) +5.51%
Aug-03-21 08:00AM	111, Inc. Enters into Strategic Cooperation Agreement with Zelgen to Develop a New Management Platform for Liver Cancer Patients in China (PR Newswire)
Jun-18-21 10:09AM	Is 111, Inc. (YI) A Good Stock To Buy? (Insider Monkey)
May-19-21 02:17AM	111, Inc. Announces First Quarter 2021 Unaudited Financial Results (PR Newswire) -16.17%
May-12-21 10:10AM	Did 111's (NASDAQ:YI) Share Price Deserve to Gain 45%? (Simply Wall St.)
Apr-21-21 08:00AM	111 to Announce First Quarter 2021 Unaudited Financial Results on May 19, 2021 - Conference Call to Follow (PR Newswire) +7.55%
Mar-25-21 05:00AM	111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform (PR Newswire)
Mar-18-21 06:10AM	111, Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results (PR Newswire) -9.52%
Mar-17-21 06:50AM	111, Inc. Enters into First-Ever Strategic Partnership with BeiGene (PR Newswire)
Mar-16-21 05:40AM	111, Inc. Achieves Full Distribution Coverage Across Mainland China with the Opening of Two Key Fulfillment Centers (PR Newswire) -6.12%
Feb-05-21 06:00AM	111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services (PR Newswire) +12.59%
Jan-01-21 03:24AM	Calculating The Intrinsic Value Of 111, Inc. (NASDAQ:YI) (Simply Wall St.)
Dec-22-20 04:22AM	111, Inc. Announces Additional Round of New Capital Injection (PR Newswire)
Nov-29-20 11:42AM	Is 111, Inc. (YI) A Good Stock To Buy Now? (Insider Monkey)
Nov-19-20 05:00AM	111, Inc. Announces Third Quarter 2020 Unaudited Financial Results (PR Newswire)
Oct-22-20 06:00AM	111 to Announce Third Quarter 2020 Unaudited Financial Results on November 19, 2020 (PR Newswire)
Oct-19-20 06:50AM	111, Inc. Teams Up with Bayer Healthcare to Explore the Vast Blue Ocean of Online Healthcare (PR Newswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chen Yang Luke	Director	Jun 12 '26	Sale	0.23	49,920	11,482	539,462	Sep 29 06:57 AM
Chen Yang Luke	Director	Jun 15 '26	Sale	0.23	44,000	10,120	495,462	Sep 29 06:57 AM
Chen Yang Luke	Director	Sep 23 '26	Sale	0.18	44,000	7,920	451,462	Sep 29 06:57 AM
Chen Yang Luke	Director	Sep 28 '26	Sale	0.18	38,120	6,862	413,342	Sep 29 06:57 AM
Chen Yang Luke	Director	May 27 '26	Sale	0.25	3,400	850	589,382	Sep 29 06:57 AM
Chen Yang Luke	Director	May 26 '26	Sale	0.27	1,440	389	592,782	Sep 29 06:57 AM
Chen Yang Luke	Director	Jun 12 '26	Sale	0.23	49,920	11,482	539,462	Sep 24 06:10 AM
Chen Yang Luke	Director	Jun 15 '26	Sale	0.23	44,000	10,120	495,462	Sep 24 06:10 AM
Chen Yang Luke	Director	Sep 23 '26	Sale	0.18	44,000	7,920	451,462	Sep 24 06:10 AM
Chen Yang Luke	Director	May 27 '26	Sale	0.25	3,400	850	589,382	Sep 24 06:10 AM
Chen Yang Luke	Director	May 26 '26	Sale	0.27	1,440	389	592,782	Sep 24 06:10 AM
Chen Yang Luke	Director	Jun 12 '26	Sale	0.23	49,920	11,482	539,462	Jun 16 06:21 AM
Chen Yang Luke	Director	Jun 15 '26	Sale	0.23	44,000	10,120	495,462	Jun 16 06:21 AM
Chen Yang Luke	Director	May 27 '26	Sale	0.25	3,400	850	589,382	Jun 16 06:21 AM
Chen Yang Luke	Director	May 26 '26	Sale	0.27	1,440	389	592,782	Jun 16 06:21 AM
Sun Jian David	Director	Jun 11 '26	Sale	0.23	111,100	25,553	472,011	Jun 16 06:18 AM
Sun Jian David	Director	Jun 10 '26	Sale	0.22	115,440	25,397	583,111	Jun 16 06:18 AM
Sun Jian David	Director	May 27 '26	Sale	0.25	70,440	17,610	710,551	Jun 16 06:18 AM
Sun Jian David	Director	Jun 15 '26	Sale	0.23	58,800	13,524	413,211	Jun 16 06:18 AM
Sun Jian David	Director	May 26 '26	Sale	0.27	29,280	7,906	780,991	Jun 16 06:18 AM
Sun Jian David	Director	Jun 09 '26	Sale	0.23	12,000	2,760	698,551	Jun 16 06:18 AM
Sun Jian David	Director	Jun 11 '26	Sale	0.23	111,100	25,553	472,011	Jun 12 06:04 AM
Sun Jian David	Director	Jun 10 '26	Sale	0.22	115,440	25,397	583,111	Jun 12 06:04 AM
Sun Jian David	Director	May 27 '26	Sale	0.25	70,440	17,610	710,551	Jun 12 06:04 AM
Sun Jian David	Director	May 26 '26	Sale	0.27	29,280	7,906	780,991	Jun 12 06:04 AM
Sun Jian David	Director	Jun 09 '26	Sale	0.23	12,000	2,760	698,551	Jun 12 06:04 AM
Sun Jian David	Director	Jun 10 '26	Sale	0.22	115,440	25,397	583,111	Jun 11 06:12 AM
Sun Jian David	Director	May 27 '26	Sale	0.25	70,440	17,610	710,551	Jun 11 06:12 AM
Sun Jian David	Director	May 26 '26	Sale	0.27	29,280	7,906	780,991	Jun 11 06:12 AM
Sun Jian David	Director	Jun 09 '26	Sale	0.23	12,000	2,760	698,551	Jun 11 06:12 AM
Sun Jian David	Director	Jun 09 '26	Proposed Sale	4.74	14,867	70,470		Jun 09 06:40 AM
Luo Jun Justin	Director	May 27 '26	Sale	0.25	70,440	17,610	710,551	May 29 08:51 AM
Luo Jun Justin	Director	May 26 '26	Sale	0.27	29,280	7,906	780,991	May 29 08:51 AM
Sun Jian David	Director	May 27 '26	Sale	0.25	70,440	17,610	710,551	May 29 08:48 AM
Sun Jian David	Director	May 26 '26	Sale	0.27	29,280	7,906	780,991	May 29 08:48 AM
Chen Yang Luke	Director	May 27 '26	Sale	0.25	3,400	850	589,382	May 29 08:46 AM
Chen Yang Luke	Director	May 26 '26	Sale	0.27	1,440	389	592,782	May 29 08:46 AM

111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

Co-Founder & Executive ChairmanDr. Gang Yu Ph.D.

Co-FounderMr. Junling Liu

IR DirectorMonica Mu

Chief Innovation OfficerMr. Anfeng Guo

Finance DirectorMr. Alex Liu

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

YI

111 Inc ADR

Upgrade your Finviz experience